135 related articles for article (PubMed ID: 12055215)
1. CD36 is differentially expressed by CD8+ splenic dendritic cells but is not required for cross-presentation in vivo.
Belz GT; Vremec D; Febbraio M; Corcoran L; Shortman K; Carbone FR; Heath WR
J Immunol; 2002 Jun; 168(12):6066-70. PubMed ID: 12055215
[TBL] [Abstract][Full Text] [Related]
2. CD36 or alphavbeta3 and alphavbeta5 integrins are not essential for MHC class I cross-presentation of cell-associated antigen by CD8 alpha+ murine dendritic cells.
Schulz O; Pennington DJ; Hodivala-Dilke K; Febbraio M; Reis e Sousa C
J Immunol; 2002 Jun; 168(12):6057-65. PubMed ID: 12055214
[TBL] [Abstract][Full Text] [Related]
3. Selection of an antibody library identifies a pathway to induce immunity by targeting CD36 on steady-state CD8 alpha+ dendritic cells.
Tagliani E; Guermonprez P; Sepúlveda J; López-Bravo M; Ardavín C; Amigorena S; Benvenuti F; Burrone OR
J Immunol; 2008 Mar; 180(5):3201-9. PubMed ID: 18292544
[TBL] [Abstract][Full Text] [Related]
4. Cutting edge: intravenous soluble antigen is presented to CD4 T cells by CD8- dendritic cells, but cross-presented to CD8 T cells by CD8+ dendritic cells.
Pooley JL; Heath WR; Shortman K
J Immunol; 2001 May; 166(9):5327-30. PubMed ID: 11313367
[TBL] [Abstract][Full Text] [Related]
5. Autophagy protein ATG5 regulates CD36 expression and anti-tumor MHC class II antigen presentation in dendritic cells.
Oh DS; Lee HK
Autophagy; 2019 Dec; 15(12):2091-2106. PubMed ID: 30900506
[TBL] [Abstract][Full Text] [Related]
6. The dominant role of CD8+ dendritic cells in cross-presentation is not dictated by antigen capture.
Schnorrer P; Behrens GM; Wilson NS; Pooley JL; Smith CM; El-Sukkari D; Davey G; Kupresanin F; Li M; Maraskovsky E; Belz GT; Carbone FR; Shortman K; Heath WR; Villadangos JA
Proc Natl Acad Sci U S A; 2006 Jul; 103(28):10729-34. PubMed ID: 16807294
[TBL] [Abstract][Full Text] [Related]
7. Route of antigen uptake differentially impacts presentation by dendritic cells and activated monocytes.
Kamphorst AO; Guermonprez P; Dudziak D; Nussenzweig MC
J Immunol; 2010 Sep; 185(6):3426-35. PubMed ID: 20729332
[TBL] [Abstract][Full Text] [Related]
8. Dendritic cells are sufficient to cross-present self-antigens to CD8 T cells in vivo.
Kurts C; Cannarile M; Klebba I; Brocker T
J Immunol; 2001 Feb; 166(3):1439-42. PubMed ID: 11160180
[TBL] [Abstract][Full Text] [Related]
9. TLR7 triggering with polyuridylic acid promotes cross-presentation in CD8α+ conventional dendritic cells by enhancing antigen preservation and MHC class I antigen permanence on the dendritic cell surface.
Crespo MI; Zacca ER; Núñez NG; Ranocchia RP; Maccioni M; Maletto BA; Pistoresi-Palencia MC; Morón G
J Immunol; 2013 Feb; 190(3):948-60. PubMed ID: 23284054
[TBL] [Abstract][Full Text] [Related]
10. Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance.
Bonifaz L; Bonnyay D; Mahnke K; Rivera M; Nussenzweig MC; Steinman RM
J Exp Med; 2002 Dec; 196(12):1627-38. PubMed ID: 12486105
[TBL] [Abstract][Full Text] [Related]
11. Antigen presentation capacity and cytokine production by murine splenic dendritic cell subsets upon Salmonella encounter.
Yrlid U; Wick MJ
J Immunol; 2002 Jul; 169(1):108-16. PubMed ID: 12077235
[TBL] [Abstract][Full Text] [Related]
12. CD8(+) but not CD8(-) dendritic cells cross-prime cytotoxic T cells in vivo.
den Haan JM; Lehar SM; Bevan MJ
J Exp Med; 2000 Dec; 192(12):1685-96. PubMed ID: 11120766
[TBL] [Abstract][Full Text] [Related]
13. Sustained cross-presentation capacity of murine splenic dendritic cell subsets in vivo.
Ho NI; Camps MGM; de Haas EFE; Ossendorp F
Eur J Immunol; 2018 Jul; 48(7):1164-1173. PubMed ID: 29676785
[TBL] [Abstract][Full Text] [Related]
14. Active CD4+ helper T cells directly stimulate CD8+ cytotoxic T lymphocyte responses in wild-type and MHC II gene knockout C57BL/6 mice and transgenic RIP-mOVA mice expressing islet beta-cell ovalbumin antigen leading to diabetes.
Ye Z; Ahmed KA; Hao S; Zhang X; Xie Y; Munegowda MA; Meng Q; Chibbar R; Xiang J
Autoimmunity; 2008 Nov; 41(7):501-11. PubMed ID: 18855194
[TBL] [Abstract][Full Text] [Related]
15. Thymic but not splenic CD8⁺ DCs can efficiently cross-prime T cells in the absence of licensing factors.
Dresch C; Ackermann M; Vogt B; de Andrade Pereira B; Shortman K; Fraefel C
Eur J Immunol; 2011 Sep; 41(9):2544-55. PubMed ID: 21748731
[TBL] [Abstract][Full Text] [Related]
16. Active dissemination of cellular antigens by DCs facilitates CD8
Gurevich I; Feferman T; Milo I; Tal O; Golani O; Drexler I; Shakhar G
Eur J Immunol; 2017 Oct; 47(10):1802-1818. PubMed ID: 28872666
[TBL] [Abstract][Full Text] [Related]
17. Immature dendritic cells phagocytose apoptotic cells via alphavbeta5 and CD36, and cross-present antigens to cytotoxic T lymphocytes.
Albert ML; Pearce SF; Francisco LM; Sauter B; Roy P; Silverstein RL; Bhardwaj N
J Exp Med; 1998 Oct; 188(7):1359-68. PubMed ID: 9763615
[TBL] [Abstract][Full Text] [Related]
18. Leishmania antigens are presented to CD8+ T cells by a transporter associated with antigen processing-independent pathway in vitro and in vivo.
Bertholet S; Goldszmid R; Morrot A; Debrabant A; Afrin F; Collazo-Custodio C; Houde M; Desjardins M; Sher A; Sacks D
J Immunol; 2006 Sep; 177(6):3525-33. PubMed ID: 16951311
[TBL] [Abstract][Full Text] [Related]
19. Antigen delivery to dendritic cells by poly(propylene sulfide) nanoparticles with disulfide conjugated peptides: Cross-presentation and T cell activation.
Hirosue S; Kourtis IC; van der Vlies AJ; Hubbell JA; Swartz MA
Vaccine; 2010 Nov; 28(50):7897-906. PubMed ID: 20934457
[TBL] [Abstract][Full Text] [Related]
20. Antigen processing and CD24 expression determine antigen presentation by splenic CD4+ and CD8+ dendritic cells.
Askew D; Harding CV
Immunology; 2008 Mar; 123(3):447-55. PubMed ID: 17949418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
